Partners’ engagement in surveillance among survivors of colorectal cancer: A qualitative study

OBJECTIVES: Following treatment of Stage III colorectal cancer, guidelines recommend 3–5 years of surveillance for recurrence. However, over half of the 1.2 million U.S. survivors of colorectal cancer fail to receive guideline‐concordant surveillance. In light of growing recognition that members of...

Descripción completa

Detalles Bibliográficos
Autores principales: Veenstra, Christine M., Acosta, Jennifer, Sharar, Rebecca, Hawley, Sarah T., Morris, Arden M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926003/
https://www.ncbi.nlm.nih.gov/pubmed/33463029
http://dx.doi.org/10.1002/cam4.3725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926003/
https://www.ncbi.nlm.nih.gov/pubmed/33463029
http://dx.doi.org/10.1002/cam4.3725

Ejemplares similares